IRCT20220407054446N1招募中未知
Evaluation of the efficacy and safety of Co-trimoxazole in patients with COVID-19: A randomized open-label clinical trial
Bandare-abbas University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age 18 years or older
- •Conscious and voluntary satisfaction
- •Definitive diagnosis of COVID-19 disease by PCR test
- •Hospitalized with early sign of moderate disease
排除标准
- •Multiple organ failure
- •Severe ARDS
- •Septic shock
- •Acute kidney injury (which GFR is <15)
- •Drug allergy / Sensitivity to drugs with sulfuric structure / Intolerance to co-trimoxazole
- •Women during pregnancy and lactation, taking other antiviral drugs, tocilizumab or plasma therapy
研究者
相似试验
进行中（未招募）
不适用
The efficacy and safety of co-trimoxazole therapy in patients with idiopathic interstitial pneumonia - TIPACIdiopathic Interstitial PneumoniaMedDRA version: 9.1Level: LLTClassification code 10022619Term: Interstitial pulmonary fibrosisEUCTR2007-002324-15-GBniversity of East Anglia
已完成
2 期
Prophylaxis of urinary tract infection(UTI)rinary tract infection.Other infectious diseasesB99,B99IRCT2015120823743N1Vice Chancellor for research of Isfahan University of Medical Sciences50
撤回
4 期
Exploring prophylactic co-trimoxazole regimens at the removal of temporary catheters to prevent urinary tract infections: a randomised placebo controlled pilot studyurinarary tract infection10004018cystitisNL-OMON35979Spaarne Ziekenhuis42
已完成
4 期
Comparison of wound dressing solutions, TCDO vs SOS, in wound healingCTRI/2017/09/009625Grant Medical College Sir Jamshedjee Jeejeebhoy Group of Hospitals
已完成
2 期
Expanded Treatment Efficacy and Safety Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Epirubicin/ Doxorubicin-Lipiodol Emulsion and Gelatin Particles: Korea-Japan Cooperative Study (JIVROSG-0604)hepatocellular carcinomaJPRN-UMIN000000975Japan Interventional Radiology in Oncology Study Group (JIVROSG)100